Skip to main content

Table 1 Clinicopathological variables of ruptured HCC patients who underwent hepatectomy with hepatic inflow occlusion(HIO) and without hepatic inflow occlusion(non-HIO)

From: The effect of the number of hepatic inflow occlusion times on the prognosis of ruptured hepatocellular carcinoma patients after hepatectomy

Variables

Non-hepatic inflow occlusion

Hepatic inflow occlusion

p-value

n = 100

n = 103

Gender (%)

  

0.104

 Male

85 (85.0)

95 (92.2)

 

 Female

15 (15.0)

8 (7.8)

 

Age (y)

43.9 ± 11.7

42.8 ± 11.4

0.498

Length (%)

  

0.437

  ≤ 5 cm

26 (26.0)

22 (21.4)

 

  > 5 cm

74 (74.0)

81 (78.6)

 

Tumor number(%)

  

0.397

 Single

81 (81.0)

78 (75.7)

 

 Multiple

19 (19.0)

25 (24.3)

 

BCLC stage (%)

  

0.009

 A

67 (67.0)

49 (47.6)

 

 B

20 (20.0)

25 (24.3)

 

 C

13 (13.0)

29 (28.2)

 

Child–Pugh (%)

  

0.219

 A

84 (84.0)

79 (76.7)

 

 B

16 (16.0)

24 (23.3)

 

AFP (%)

  

0.470

  ≤ 400 ng/ml

39 (39.0)

35 (34.0)

 

  > 400 ng/ml

61 (61.0)

68 (66.0)

 

Edmondson-steiner(%)

  

0.057

 I

13 (13.0)

8 (7.8)

 

 II

36 (36.0)

54 (52.4)

 

 III

33 (33.0)

21 (20.4)

 

 IV

18 (18.0)

20 (19.4)

 

Necrosis (%)

  

0.086

 No

68 (68.0)

81 (78.6)

 

 Yes

32 (32.0)

22 (21.4)

 

Local invasion (%)

  

0.437

 No

46 (46.0)

53 (51.5)

 

 Yes

54 (54.0)

50 (48.5)

 

ALB(g/L)

35.2 (32.3–38.6)

35.9 (33.1–38.8)

0.516

ALT(U/L)

27.0 (21.0–41.0)

28.0 (21.0–41.0)

0.548

AST(U/L)

36.5 (28.0–61.3)

37.0 (24.0–66.0)

0.919

ALP(U/L)

76.0 (56.0–93.0)

75.0 (61.0–93.0)

0.223

GGT(U/L)

47.0 (28.3–91.0)

58.0 (36.0–129.0)

0.074

HBsAg(%)

  

0.078

 No

17 (17.0)

9 (8.7)

 

 Yes

83 (83.0)

94 (91.3)

 
  1. BCLC, Barcelona Clinic Liver Cancer; AFP, alpha fetoprotein; ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, Îł-glutamyl transpeptidase; HIO, hepatic inflow occlusion